117
Views
16
CrossRef citations to date
0
Altmetric
Psychological Disorders

Pitfalls in Respiratory Allergy Management: Alexithymia and Its Impact on Patient-Reported Outcomes

, , , , , , , , & show all
Pages 25-32 | Published online: 01 Dec 2010

References

  • Taylor GJ, Bagby RM, Parker JDA, eds. Disorders of Affect Regulation. Alexithymia in Medical and Psychiatric Illness. Cambridge: Cambridge University Press, 1997: 26–45.
  • Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother Psychosom 2004; 73: 68–77.
  • Sifneos PE. The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 1973; 22: 255–262.
  • Larsen JK, Brand N, Bermond B, Hijman R. Cognitive and emotional characteristics of alexithymia: a review of neurobiological studies. J Psychosom Res 2003; 54: 533–541.
  • Picardi A, Mazzotti E, Gaetano P, Cattaruzza MS, Baliva G, Melchi CF, Biondi M, Pasquini P. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics 2005; 46:556–564.
  • Richards HL, Fortune DG, Griffiths CE, Main CJ. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res 2005; 58: 89–96.
  • Joukamaa M, Taanila A, Miettunen J, Karvonen JT, Koskinen M, Veijola J. Epidemiology of Alexithymia among adolescents. J Psychosom Res 2007; 63:373–376.
  • Salminen JK, Saarijärvi S, Aärelä E, Toikka T, Kauhanen J. Prevalence of alexithymia and its association with sociodemographicvariables in the general population of Finland. J Psychosom Res 1999; 46:75–82.
  • Honkalampi K, Hintikka J, Tanskanen A, Lehtonen J, Viinamäki H. Depression is strongly associated with alexithymia in the general population. J Psychosom Res 2000; 48:99–104.
  • Porcelli P, Leoci C, Guerra V, Taylor GJ, Bagby RM. A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychosom Res 1996; 41: 569–573.
  • Kojima M, Frasure-Smith N, Lesperance F. Alexithymia following myocardial infarction: psychometric properties and correlates of the Toronto Alexithymia Scale. J Psychosom Res 2001; 51: 487–495.
  • Serrano J, Plaza V, Sureda B, de Pablo J, Picado C, Bardagí S, Lamela J, Sanchis J,. Spanish High Risk Asthma Resrarch Group. Alexithymia: a relevant psychological variable in near-fatal asthma. Eur Respir J 2006; 28:296–302.
  • Kauhanen J, Kaplan GA, Cohen RD, Julkunen J, Salonen JT. Alexithymia and risk of death in middle-age men. J Psichosom Res 1996;41:541–549.
  • Lumley MA, Stettner L, Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996; 41: 505–518.
  • Bruni R, Serino FM, Galluzzo S, Coppolino G, Cacciapaglia F, Vadacca M, Nilo S, Terminio N, Afeltra A. Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases. Preliminary results on relationship between alexithymic construct and TNF alpha levels. Ann N YAcad Sci 2006;1069:208–211.
  • Porcelli P, Zaka S, Leoci C, Centonze S, Taylor GJ. Alexithymia in inflammatory bowel disease: a case-control study. Psychother Psychosom 1995; 64:49–53.
  • Fernandez A, Sriram TG, Rajkumar S, Chandrasekar AN. Alexithymic characteristics in rheumatoid arthritis: a controlled study. Psychother Psychosom 1989; 51(1):45–50.
  • Dewaraja R, Tanigawa T, Araki S, Nakata A, Kawamura N, Ago Y, Sasaki Y. Decreased cytotoxic lymphocyte counts in alexithymia. Psychother Psychosom 1994; 61: 199–204.
  • Guilbaud O, Corcos M, Hjalmarsson L, Loas G, Jeammet P. Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomed Pharmacother 2003; 57: 292–295.
  • Corcos M, Guilbaud O, Paterniti S, Curt F, Hjalmarsson L, Moussa M, Chambry J, Loas G, Chaouat G, Jeammet P. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Psychoneuroendocrinology 2004; 29: 686–691.
  • Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 12: 1697–1704.
  • Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 1996;108:37–81.
  • Druet P, Sheela R, Pelletier L. Th1 and Th2 cells in autoimmunity. Chem Immunol 1996; 63:138–170.
  • Guilbaud O, Curt F, Perrin C, Chaouat G, Berthoz S, Dugré–Le Bigre C, Wallier J, Strebler M, Touitou C, Jeammet P, Corcos M. Decreased immune response in alexithymic women: a cross-sectional study. Biomed Pharmacother. 2009;63:297–304.
  • Berthoz S, Artiges E, Van de Moortele PF, Poline JB, Rouquette S, Consoli SM, Martinot JL. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Am J Psychiatry 2002; 159:961–967.
  • Moriguchi Y, Ohnishi T, Lane RD, Maeda M, Mori T, Nemoto K, Matsuda H, Komaki G. Impaired self awareness and theory of mind: an fMRI study of mentalizing in alexithymia. Neuroimage 2006; 32:1472–1482.
  • Kano F, Fukudo S, Gyoba J, Kamachi M, Tagawa M, Mochizuki H, Itoh M, Hongo M, Yanai K. Specific brain processing of facial expressions in people with alexithymia: an H(2)(15)-O-PET study. Brain 2003;126:1474–1484.
  • Gündel H, López–Sala A, Ceballos-Baumann AO, Deus J, Cardoner N, Marten-Mittag B, Soriano-Mas C, Pujol J. Alexithymia correlates with the size of the right anterior cingulate. Psychosom Med 2004; 66:132–140.
  • Borsci G, Boccardi M, Rossi, R, Rossi G, Perez J, Bonetti M, Frisoni GB. Alexithymia in healthy women: a brain morphology study. J Affect Disord 2009; 114(1–3):208–215.
  • Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995;118:279–306.
  • Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 2001; 935:107–117.
  • Rosenkranz MA, Busse WW, Johnstone T, Swenson CA, Crisafi GM, Jackson MM, Bosch JA, Sheridan JF, Davidson RJ. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci U S A. 2005; 102:13319–13324.
  • Brown EL, Fukuhara JT, Feiguine RJ. Alexithymic asthmatics: the miscommunication of affective and somatic states. Psychother Psychosom 1981; 36:116–121
  • Dirks JF, Robinson SK, Dirks DL. Alexithymia and the psychomaintenance of bronchial asthma. Psychother Psychosom 1981; 36:63–71
  • Baiardini I, Bousquet PJ, Brzoza Z, Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, van Wijk RG, La Grutta S, Lombardi C, Maurer M, Pinto AM, Ridolo E, Senna GE, Terreehorst I, Bom AT, Bousquet J, Zuberbier T, Braido F; Global Allergy and Asthma European Network. Recommendations for assessing Patient-Reported Outcomes and Health-Related Quality of Life in clinical trials on allergy: a Ga(2)len taskforce position paper. Allergy 2010; 65:290–295.
  • Mattila AK, Saarni SI, Salminen JK, Huhtala H, Sintonen H, Joukamaa M. Alexithymia and health-related quality of life in a general population. Psychosomatics 2009; 50:59–68.
  • Feldman JM, Lehrer PM, Hochron SM. The predictive value of the Toronto Alexithymia Scale among patients with asthma. J Psychosom Res 2002; 53:1049–1052.
  • Chugg K, Barton C, Antic R, Crockett A. The impact of alexithymia on asthma patient management and communication with health care providers: a pilot study. J Asthma 2009; 46:126–129.
  • Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aít-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 86:8–160.
  • Global Initiative for asthma (GINA). Global strategy for asthma management and prevention. Revised 2006. Available at: http://www.ginasthma.com. Accessed January 14, 2010.
  • Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994; 38:23–32.
  • Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale-II. Covergent, discriminant and concurrent validity. J Psychosom Res 1994; 38:33–40.
  • Haviland MG, Reise SP. Structure of the twenty-item Toronto Alexithymia Scale. J Pers Assess 1996; 66:116–125.
  • Taylor CG, Bagby RM, Parker JD. The 20-item Toronto Alexithymia Scale- IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res 2003; 55:277–283.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59–65.
  • Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117:549–556.
  • Braido F, Baiardini I, Balestracci S, Ghiglione V, Stagi E, Ridolo E, Nathan R, Canonica GW. Does asthma control correlate with quality of life related to upper and lower airways? A real life study. Allergy 2009; 64:937–943
  • Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S, Braido F, Bonini S, Majani G, Canonica GW. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003; 58:289–294.
  • Pasquali M, Baiardini I, Rogkakou A, Riccio AM, Gamalero C, Descalzi D, Folli C, Passalacqua G, Canonica GW. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006; 36:1161–1167.
  • Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health 2002; 17:116.
  • McNair DM, Lorr M, Droppleman LF. POMS Manual: Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1992.
  • Boyle, GJ. A cross-validation of the factorstructure of the profile of mood states: were the factors correctly identified in the first instance? Psychological Reports 1987; 60:343–354.
  • Norcross JC, Guadagnoli E, Prochaska JO. Factor structure of the profile of mood states (POMS): two partial replications. J Clin Psychol 1984; 40:1270–1277.
  • Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996; 31:792–796.
  • Richards HL, Fortune DG, Griffiths CE, Main CJ. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res 2005; 58:89–96.
  • Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007; 29:56–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.